We are live on ! Find out more
SQZ

SQZ Biotechnologies Company
SQZ

Delisted

SQZ was delisted on the 3rd of July, 2023.

Back to rankings

44 hedge funds and large institutions have $199M invested in SQZ Biotechnologies Company in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 14

25% more capital invested

Capital invested by funds: $159M → $199M (+$39.7M)

10% less funds holding

Funds holding: 49 → 44 (-5)

71% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 7

Holders
44
Holders Change
-5
Holders Change %
-10.2%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
20
Reduced
14
Closed
7
Calls
$164K
Puts
–
Net Calls
+$164K
Net Calls Change
+$164K

Top Buyers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
+$4.3M
2
Temasek Holdings
Temasek Holdings
Singapore
+$3.04M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.69M
4
MC
Maverick Capital
Texas
+$999K
5
JP Morgan Chase
JP Morgan Chase
New York
+$745K

Top Sellers

Rank Fund Capital Flow
1
LM
Luminus Management
Texas
-$5.11M
2
Morgan Stanley
Morgan Stanley
New York
-$2.14M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$1M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$668K
5
JF
Jump Financial
Illinois
-$389K
Name Holding Trade Value Shares
Change 		Change in
Stake
HI
51
Harbour Investments
Wisconsin
– -$81 -6 -32%
1 2
3

SQZ Hedge Fund Activity: Q3 2021 in Review

44 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q3 2021, worth a combined $199M — up 25% from $159M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of SQZ and 2 opened new positions — a net loss of 5 holders — while 14 trimmed existing stakes and 20 added.

The largest buyer was 683 Capital Management, adding an estimated $4.3M. The largest seller was Luminus Management, exiting entirely with an estimated $5.11M sold.

  • 44 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q3 2021, down from 49 in Q2 2021.
  • Funds reported $199M of SQZ Biotechnologies Company stock for Q3 2021, up 25% quarter-over-quarter.
  • 2 funds opened new SQZ Biotechnologies Company positions in Q3 2021 and 7 closed out, a net change of -5 holders.
  • The largest SQZ Biotechnologies Company buyer in Q3 2021 was 683 Capital Management, an estimated $4.3M added.
  • The largest SQZ Biotechnologies Company seller in Q3 2021 was Luminus Management, an estimated $5.11M sold.

Based on aggregated 13F filings for Q3 2021.